Guo Meng
Director/Board Member chez SSY GROUP LIMITED
Fortune : 13 M $ au 31/03/2024
Profil
Guo Meng is currently an Executive Director & Deputy General Manager at SSY Group Ltd., a Director at New Orient Investments Pharmaceutical Holding (Hong Kong) Ltd., and a Director at Hebei Guolong Pharmaceutical Co., Ltd.
Previously, Mr. Meng served as the Executive President & Director at Shijiazhuang No.
4 Pharmaceutical Co., Ltd.
Mr. Meng's education includes an undergraduate degree from Lanzhou University and a graduate degree from Beijing University of Technology.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
SSY GROUP LIMITED
0,67% | 30/06/2023 | 20 000 000 ( 0,67% ) | 13 M $ | 31/03/2024 |
Postes actifs de Guo Meng
| Sociétés | Poste | Début |
|---|---|---|
| SSY GROUP LIMITED | Director/Board Member | 27/08/2021 |
New Orient Investments Pharmaceutical Holding (Hong Kong) Ltd.
 New Orient Investments Pharmaceutical Holding (Hong Kong) Ltd. Financial ConglomeratesFinance Part of SSY Group Ltd., New Orient Investments Pharmaceutical Holding (Hong Kong) Ltd. operates as an investment holding Samoan company. The private company is based in Chaoyan, Samoa. New Orient Investments Pharmaceutical Holding (Hong Kong was acquired by SSY Group Ltd. from CMP Group Ltd. (Samoa) on June 29, 2007 for $91.31 million. | Director/Board Member | - |
| Hebei Guolong Pharmaceutical Co., Ltd. | Director/Board Member | - |
Anciens postes connus de Guo Meng
| Sociétés | Poste | Fin |
|---|---|---|
Shijiazhuang No. 4 Pharmaceutical Co., Ltd.
 Shijiazhuang No. 4 Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Shijiazhuang No.4 Pharmaceutical Co., Ltd. is a pharmceutical company in China. It offers medicines in forms of infusions, capsules, granules, tablets & oral liquids among others. The company was founded in 1948 and is headquartered in Hebei, CN. | President | - |
Formation de Guo Meng
| Lanzhou University | Undergraduate Degree |
| Beijing University of Technology | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| SSY GROUP LIMITED | Health Technology |
| Entreprise privées | 3 |
|---|---|
New Orient Investments Pharmaceutical Holding (Hong Kong) Ltd.
New Orient Investments Pharmaceutical Holding (Hong Kong) Ltd. Financial ConglomeratesFinance Part of SSY Group Ltd., New Orient Investments Pharmaceutical Holding (Hong Kong) Ltd. operates as an investment holding Samoan company. The private company is based in Chaoyan, Samoa. New Orient Investments Pharmaceutical Holding (Hong Kong was acquired by SSY Group Ltd. from CMP Group Ltd. (Samoa) on June 29, 2007 for $91.31 million. | Finance |
Shijiazhuang No. 4 Pharmaceutical Co., Ltd.
Shijiazhuang No. 4 Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Shijiazhuang No.4 Pharmaceutical Co., Ltd. is a pharmceutical company in China. It offers medicines in forms of infusions, capsules, granules, tablets & oral liquids among others. The company was founded in 1948 and is headquartered in Hebei, CN. | Health Technology |
| Hebei Guolong Pharmaceutical Co., Ltd. |
